Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease
Author: Sorin Brener
Publsiher: Academic Press
Total Pages: 220
Release: 2021-01-09
ISBN 10: 0128205377
ISBN 13: 9780128205372
Language: EN, FR, DE, ES & NL

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease Book Review:

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to understand platelet physiology and its relevance to ischemic events. Data on shorter than usual duration of DAPT, and on extended therapy beyond the recommendation of current guidelines is presented in great detail, summarizing a large body of evidence into concrete, relevant recommendation that is readily adaptable by practicing clinicians. A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years. Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians Explores the current status of DAPT, controversial topics, and future developments and trends in this field Edited and contributed by renowned cardiologists in the field

Clinical Guide to Cardiology

Clinical Guide to Cardiology
Author: Christian Fielder Camm,A. John Camm
Publsiher: John Wiley & Sons
Total Pages: 440
Release: 2016-03-07
ISBN 10: 1118755332
ISBN 13: 9781118755334
Language: EN, FR, DE, ES & NL

Clinical Guide to Cardiology Book Review:

Clinical Guide to Cardiology is a quick-reference resource, packed full of bullet points, diagrams, tables and algorithms for the key concepts and facts for important presentations and conditions within cardiology. It provides practical, evidence-based information on interventions, investigations, and the management of clinical cardiology. Key features include: A clear evidence-base providing key guidelines and clinical trials in each chapter Coverage of examination techniques, common conditions, imaging modalities (including ECGs, chest X-rays, MRI and CT), interventional therapies, and pharmacology A companion website at www.wiley.com/go/camm/cardiology featuring audio clips, developed for differing levels of knowledge, that explain key concepts or an area in greater detail, as well as numerous additional clinical case studies, audio scripts, and self-assessment material

Peripheral and Cerebrovascular Intervention

Peripheral and Cerebrovascular Intervention
Author: Deepak L. Bhatt
Publsiher: Springer Science & Business Media
Total Pages: 236
Release: 2011-11-20
ISBN 10: 9781603279659
ISBN 13: 1603279652
Language: EN, FR, DE, ES & NL

Peripheral and Cerebrovascular Intervention Book Review:

Peripheral and Cerebrovascular Intervention draws upon experts from diverse fields to provide readers with a comprehensive foundation for understanding and performing endovascular procedures—from the basic steps to the most current and advanced techniques. Individual chapters focus on primary intervention sites, including lower extremity, renal/mesenteric, subclavian/upper extremity, carotid/vertebral, intracranial and venous interventions. Additionally, chapters covering critical limb ischemia and abdominal and thoracic aortic aneurysms are included. By incorporating valuable clinical information, such as indications, contraindications, complications and discussions of surgical techniques and procedures, this book is a valuable resource for the busy practitioner and will be of interest to all interventional and general cardiologists, radiologists and neurologists; vascular surgeons; internists and residents and fellows.

Drug Coated Balloons

Drug Coated Balloons
Author: Bernardo Cortese
Publsiher: Springer
Total Pages: 234
Release: 2019-06-19
ISBN 10: 3319926004
ISBN 13: 9783319926001
Language: EN, FR, DE, ES & NL

Drug Coated Balloons Book Review:

This book provides a comprehensive, up-to-date summary of drug-coated balloon (DCB) technology and the role of DCBs in the treatment of coronary and peripheral arterial disease. In addition to clear explanation of how DCBs works, readers will find an enlightening analysis of the mistakes and successes of the past decade and the emergence of the latest delivery systems, which combine a more deliverable device with much improved drug delivery to the vessel wall. The full range of current applications of DCBs are reviewed in detail, drawing on the latest scientific evidence. Due attention is paid to newer devices, with provision of technical insights and documentation of the available clinical data. Ongoing research projects, remaining technical challenges, likely future directions, and reimbursement issues are also carefully considered. This book will be a useful tool for any interventional cardiologist, interventional radiologist, or vascular surgeon who wishes to acquire a deep knowledge of this technology and its application in both coronary and peripheral interventions.

Bioresorbable Scaffolds

Bioresorbable Scaffolds
Author: Yoshinobu Onuma,Patrick W.J.C. Serruys
Publsiher: CRC Press
Total Pages: 533
Release: 2017-10-02
ISBN 10: 1498779778
ISBN 13: 9781498779777
Language: EN, FR, DE, ES & NL

Bioresorbable Scaffolds Book Review:

This book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic stent. The book provides an overview of the technology including non-clinical studies and clinical evidences in order to help clinicians understand the appropriate application of the technology and the optimal techniques of implantation. It covers the basics of bioresorbable scaffolds; bench test results; preclinical studies; clinical evidences; and tips and tricks of implantation.

Antiplatelet Therapy in Cardiovascular Disease

Antiplatelet Therapy in Cardiovascular Disease
Author: Ron Waksman,Paul A. Gurbel,Michael A. Gaglia, Jr.
Publsiher: John Wiley & Sons
Total Pages: 352
Release: 2014-03-24
ISBN 10: 1118494024
ISBN 13: 9781118494028
Language: EN, FR, DE, ES & NL

Antiplatelet Therapy in Cardiovascular Disease Book Review:

Edited by one of the world's leading interventional cardiologistsand educators, this new book is created with an eye on giving thereader a solid, practical and clinically-focused understanding ofthis important class of drugs, from basic science to a clear-headeddiscussion of complex topics such as combination therapies,drug-drug interactions, and platelet resistance. This important new book: Begins with a concise but thorough discussion of plateletbiology and pathophysiology so that readers understand how thesetherapies work and why they can also produce such a varied range ofcomplications, from minor gastrointestinal upset, to potentiallylife-threatening conditions such as neutropenia, a criticalshortage of white blood cells. Thoroughly covers platelet function testing, including new,novel techniques. Clarifies current best-practices regarding the use ofantiplatelet agents in both chronic and acute cardiovasculardisease Reviews of all types of antiplatelet agents – fromaspirin to recently approved drugs – including indications,clinical outcomes, and side effects/complications Written by an international who's-who of experts in the field,Antiplatelet Therapy also includes an entire section covering theuse of antiplatelet drugs in PCIs, including percutaneous valverepair, which makes this text particularly essential toInterventional Cardiologists.

Antiplatelet and Anticoagulation Therapy

Antiplatelet and Anticoagulation Therapy
Author: Albert Ferro,David A. Garcia
Publsiher: Springer Science & Business Media
Total Pages: 247
Release: 2012-10-13
ISBN 10: 1447142969
ISBN 13: 9781447142966
Language: EN, FR, DE, ES & NL

Antiplatelet and Anticoagulation Therapy Book Review:

This title will be presented as highly practical information pn pharmaceutical antiplatelet and anticoagulation therapy, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series. Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

Guidelines for Antithrombotic Therapy

Guidelines for Antithrombotic Therapy
Author: Jack Hirsh
Publsiher: Pmph USA Limited
Total Pages: 184
Release: 2008-01-01
ISBN 10: 9781607950097
ISBN 13: 160795009X
Language: EN, FR, DE, ES & NL

Guidelines for Antithrombotic Therapy Book Review:

Includes a new chapter addressing the management of patients who are treated with anti-coagulants or anti-platelet drugs Provides a detail summary to each chapter, documenting the therapeutic recommendations Updates on important clinical trials since last edition

Antithrombotic Therapy

Antithrombotic Therapy
Author: Richard C. Becker,Dan J. Fintel,David Green
Publsiher: Professional Communications
Total Pages: 464
Release: 2010-12-31
ISBN 10: 1932610634
ISBN 13: 9781932610635
Language: EN, FR, DE, ES & NL

Antithrombotic Therapy Book Review:

Care of patients with atherothrombosis involving the cardiovascular, pheripheral vascular, and cerebrovascular systems.

Lower Extremity Arterial Disease

Lower Extremity Arterial Disease
Author: Dennis G. Caralis,George L. Bakris
Publsiher: Springer Science & Business Media
Total Pages: 306
Release: 2007-11-15
ISBN 10: 1592598811
ISBN 13: 9781592598816
Language: EN, FR, DE, ES & NL

Lower Extremity Arterial Disease Book Review:

A comprehensive review the state-of-the-art in atherosclerosis of the arteries of the legs and feet. The authors discuss in detail the primary symptom-claudication-an intermittent pain in the leg or foot while walking, its predisposing factors, the current diagnostic methodologies, the impressive advances in the therapeutic armamentarium, and the need to screen for co-existing coronary artery disease. Additional chapters describe cutting-edge noninvasive angiography and vascular flow studies, specific drug therapy for claudication, regression of atherosclerosis therapy, gene therapy, and drug eluting stents for peripheral arterial disease. The authors also examine the epidemiology of LEAD, the effects of smoking and effective smoking cessation programs, its pathogenesis and its association with lipid abnormalities and hypertension, aggressive risk factor modification, and the need to measure the ankle brachial index of every patient over 45.

The ESC Textbook of Cardiovascular Medicine

The ESC Textbook of Cardiovascular Medicine
Author: A. John Camm
Publsiher: Unknown
Total Pages: 3198
Release: 2019
ISBN 10: 9780198824879
ISBN 13: 0198824874
Language: EN, FR, DE, ES & NL

The ESC Textbook of Cardiovascular Medicine Book Review:

Cardiovascular Intervention A Companion to Braunwald s Heart Disease E Book

Cardiovascular Intervention  A Companion to Braunwald   s Heart Disease E Book
Author: Deepak L. Bhatt
Publsiher: Elsevier Health Sciences
Total Pages: 544
Release: 2015-03-22
ISBN 10: 0323263615
ISBN 13: 9780323263610
Language: EN, FR, DE, ES & NL

Cardiovascular Intervention A Companion to Braunwald s Heart Disease E Book Book Review:

Introducing Cardiovascular Intervention, a comprehensive companion volume to Braunwald’s Heart Disease. This medical reference book contains focused chapters on how to utilize cutting-edge interventional technologies, with an emphasis on the latest protocols and standards of care. Cardiovascular Intervention also includes late-breaking clinical trials, "Hot off the Press" commentary, and Focused Reviews that are relevant to interventional cardiology. View immersive videos from an online library of procedural clips located on Expert Consult. Remain abreast of the newest interventional techniques, including next-generation stents, invasive lesion assessment, and methods to tackle complex anatomy. Provide optimal patient care with help from easy-to-access information on the latest diagnostic and treatment advances, discussions on percutaneous approaches to structural heart disease, and new developments in treating heart valve disease.

The Management of Acute Coronary Syndromes

The Management of Acute Coronary Syndromes
Author: Peter M Schofield
Publsiher: CRC Press
Total Pages: 256
Release: 2000-01-21
ISBN 10: 9781853177194
ISBN 13: 1853177199
Language: EN, FR, DE, ES & NL

The Management of Acute Coronary Syndromes Book Review:

With new drug developments and indications for existing drugs, combined with increasing awareness of the pathophysiology and dire consequences of untreated acute coronary syndromes acute myocardial infarction and unstable angina, Schofield and colleagues present their hands-on experience with new therapeutic measures and interventional techniques for treating these syndromes. It is a practical, easy-to-read guide to effective management.

The Cleveland Clinic Cardiology Board Review

The Cleveland Clinic Cardiology Board Review
Author: Brian P. Griffin,Curtis M. Rimmerman,Eric J. Topol
Publsiher: Lippincott Williams & Wilkins
Total Pages: 809
Release: 2006-11-01
ISBN 10: 9780781759427
ISBN 13: 0781759420
Language: EN, FR, DE, ES & NL

The Cleveland Clinic Cardiology Board Review Book Review:

The Cleveland Clinic Cardiology Board Review offers thorough preparation for board certification and recertification exams in cardiology. It is written by distinguished clinicians from the Cleveland Clinic Foundation's Department of Cardiovascular Medicine and based on the Cleveland Clinic Foundation's popular annual Intensive Review of Cardiology course. In 62 chapters, the book provides a comprehensive, state-of-the-art review of every area of contemporary cardiovascular medicine. Emphasis is on board relevant clinical material and accurate real-world clinical decision making. More than 400 illustrations and numerous tables facilitate quick review. Board-format questions with answers and explanations appear at the end of each section.

Prevention and Treatment of Ischemic Stroke

Prevention and Treatment of Ischemic Stroke
Author: Scott Eric Kasner,Philip B. Gorelick
Publsiher: Butterworth-Heinemann
Total Pages: 416
Release: 2004
ISBN 10: 9780750674645
ISBN 13: 0750674644
Language: EN, FR, DE, ES & NL

Prevention and Treatment of Ischemic Stroke Book Review:

This volume covers prevention and treatment options for both primary and secondary ischemic stroke; offers practical, scientific guidance on all aspects of patient care, including critical care management and rehabilitation; provides author recommendations where clinical answers are not yet clear; and discusses topics such as diagnostic evaluation of TIA and ischemic stroke, large vessel atherosclerosis, small vessel occlusive disease, ususual and cryptogenic etiologies of stroke, and emerging therapies.

Management of Dyslipidemia

Management of Dyslipidemia
Author: Wilbert S. Aronow
Publsiher: BoD – Books on Demand
Total Pages: 174
Release: 2021-07-21
ISBN 10: 1839685077
ISBN 13: 9781839685071
Language: EN, FR, DE, ES & NL

Management of Dyslipidemia Book Review:

Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood.

EPIDURAL ANESTHESIA FOR MANAGEMENT OF PSEUDO ANEURYSM OF FEMORAL ARTERY IN ASA IV PATIENT ON DUAL ANTIPLATELET THERAPY CASE REPORT PARADIGM SHIFT IN ANAESTHESIA PRACTICE

EPIDURAL ANESTHESIA FOR MANAGEMENT OF PSEUDO ANEURYSM OF FEMORAL ARTERY IN ASA  IV PATIENT ON DUAL ANTIPLATELET THERAPY  CASE REPORT PARADIGM SHIFT IN ANAESTHESIA PRACTICE
Author: Sherif Abeer
Publsiher: Unknown
Total Pages: 135
Release: 2017
ISBN 10: 1928374650XXX
ISBN 13: OCLC:1163822074
Language: EN, FR, DE, ES & NL

EPIDURAL ANESTHESIA FOR MANAGEMENT OF PSEUDO ANEURYSM OF FEMORAL ARTERY IN ASA IV PATIENT ON DUAL ANTIPLATELET THERAPY CASE REPORT PARADIGM SHIFT IN ANAESTHESIA PRACTICE Book Review:

Epidural anesthesia for management of pseudo aneurysm of femoral artery in ASA- IV patient on dual antiplatelet therapy: Case report and a paradigm shift in anaesthesia practiceAbeer A. Sherif, MD(1), Abdulatif Araji, MD(2) (1) Professor of anaesthesia & Pain medicine, Faculty of Medicine, El-menufia university, Consultant & Chief anaesthesiologist NMC royal hospital UAE (2) Vascular surgeon, NMC Royal hospital, UAEIntroduction: Anticoagulation achieved with dual antiplatelet therapy is becoming increasingly common after coronary angioplasty and represents an everyday challenge to the anaesthesiologists when neuraxial anaesthesia is to be considered specially in high risk patients with multiple comorbidities. Epidural hematoma is a rare but potentially devastating complication of neuraxial anesthesia. To date, no clear data addressing the safety of epidural anesthesia in patients on dual antiplatelet therapy. Despite being extremely rare, the development of epidural hematoma is a known risk after epidural analgesia. The third National Audit Project of the Royal College of Anesthetists found an incidence of two in 100 000 cases. The incidence of spontaneous epidural hematoma is rarer, estimated at 1 per 1 000 000 patients per year, most going undetected. Antiplatelet agents are known to be protective in most patients at increased risk of occlusive vascular events, including those with an acute myocardial infarction, ischemic stroke, angina, peripheral arterial disease, or atrial fibrillation. Brilianta (ticagrelor) is a platelet adenosine diphosphate (ADP) P2Y12 receptor inhibitor, a new oral anticoagulants are approved for a variety of clinical syndromes like coronary artery disease, peripheral vascular disease, or ischaemic strokes. Current ASRA recommendations to stop Brilianta (Ticagrelor) therapy 5 - 7 days before the surgery are based on level III evidence such as clinical judgement and sporadic case reports of epidural hematoma after regional analgesia, in patients with a history of taking Tecagrelor in combination with other anticoagulants ( level C evidence). To date, no prospective studies have investigated the safety of epidural analgesia in patients actively taking Ticagrelor.Methods: A 80-year-old man presented with a history of swelling and redness in his left groin. Patients was on aspirin and brilianta after angioplasty 3 month ago, ischemic nephropathy, COPD, sever chest infection, heart failure and pacemaker in place. Epidural anesthesia was planned because of the poor general condition of the patient. Epidural was conducted in the sitting position using L 3- 4 interspaces, 10 ml of bupivacaine 0.5% was injected in the epidural catheter. Primary repair of the femoral vein performed, along with the patching of the left common femoral artery. The surgical procedure lasted for 6 hours and the patient was shifted to ICU for monitoring. The intraoperative as well as the postoperative period remained uneventful.Discussion:The risk of central neuraxial blockade in patients treated with newer antiplatelet drugs is unclear. However, a disturbing lack of data exists concerning the safety of neuroaxial blockade in such patients, with a wide difference in opinion not only among anesthetists but also between published guidelines. The American Society of Regional Anesthesia agreed on an interval of 5 - 7 days between discontinuation of Brilianta (Ticagrelor) therapy and neuraxial blockade. In the current case the patient had recently undergone a coronary artery stent implantation and was treated with both Brilianta, and aspirin. Despite this dual antiplatelet therapy, uneventful epidural anesthesia at two levels was carried out. Our case report demonstrate that, for certain high-risk patients, the benefit of placing an epidural catheter while actively taking antiplatelet therapy may be considered. Conclusion:Epidural anesthesia was conducted safely for emergency vascular surgery, in high risk patient with multiple comorbidities. Decision to perform regional anesthesia in the patients receiving antithrombotic drugs should be made on an individual basis weighing risk of epidural hematoma with the benefits of regional anesthesia. This report is not meant to recommend the liberal placement of epidural catheters in patients actively taking dual antiplatelet therapy. prospective studies with a large number of patients are needed in order to give more accurate recommendation regarding performing epidural block in such population.References: 1-tHorlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172u201397.2-tCook T, Counsell D, Wildsmith J. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 2009; 102: 179u201390.3-tHorlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Regional Anesthesia and Pain Medicine 2003; 28: 172u201397.

Vascular Diseases for the Non Specialist

Vascular Diseases for the Non Specialist
Author: Tulio Pinho Navarro,Alan Dardik,Daniela Junqueira,Ligia Cisneros
Publsiher: Springer
Total Pages: 279
Release: 2017-01-03
ISBN 10: 3319460595
ISBN 13: 9783319460598
Language: EN, FR, DE, ES & NL

Vascular Diseases for the Non Specialist Book Review:

This book aims to provide non-specialist healthcare practitioners with current, focused and objective information on the most common vascular diseases encountered in daily clinical practice. In day-to-day clinical practice many healthcare practitioners do not have a working knowledge of the most common vascular diseases that frequently arise in patient care. Some of these topics include: aneurysms, peripheral arterial disease, diabetic foot, venous thromboembolism, cerebrovascular disease, aortic dissection, and acute limb ischemia. These commonly encountered vascular diseases are becoming public health issues due to their high morbidity and mortality as well as increasing healthcare costs. Since patients with vascular diseases are often referred to non-specialists, the general practitioner must know how to proper handle the most common vascular diseases encountered in daily clinical practice. For each disease the concept, epidemiology, natural history, diagnosis and treatment are described, followed by essential advice on what the non-specialist can do for the patient and when to refer the patient to a specialist.

Testing of Cyp2c19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment

Testing of Cyp2c19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment
Author: Agency for Healthcare Research and Quality,U.s. Department of Health and Human Services
Publsiher: CreateSpace
Total Pages: 362
Release: 2015-02-11
ISBN 10: 9781508439332
ISBN 13: 1508439338
Language: EN, FR, DE, ES & NL

Testing of Cyp2c19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment Book Review:

Platelets play a role in the development of atherosclerotic vascular diseases such as acute and chronic coronary artery disease, ischemic cerebrovascular disease (i.e., ischemic stroke or transient ischemic attack), and peripheral arterial disease. Specifically, platelet activation and aggregation, and the interaction of platelets with blood cells and the endothelium, contribute to the pathophysiology of these diseases. Furthermore, platelets participate in thrombus formation in the setting of atrial fibrillation. Because of the importance of platelets in disease processes that often culminate in major adverse clinical events (e.g., myocardial infarction, ischemic stroke, or cardiovascular death), there is a strong rationale for the development of therapies specifically targeting platelet function for the primary and secondary prevention of cardiovascular disease. Because patient response to antiplatelet treatments is variable, there is also great interest in developing biomarkers to predict treatment response and guide treatment selection. Approximately 82 million Americans currently suffer from some form of cardiovascular disease. Randomized controlled trials have established dual antiplatelet treatment with clopidogrel and aspirin as the current standard of care for medical and interventional management of acute coronary syndromes. Dual antiplatelet treatment is also recommended for patients undergoing PCI with placement of stents (either bare metal or drug eluting). Randomized controlled trials support the use of clopidogrel in patients who have experienced acute cardiovascular events (e.g., stroke) and those with peripheral arterial disease. For patients with atrial fibrillation and contraindications to vitamin K antagonists, the ACTIVE A (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) trial suggested that the combination of clopidogrel and aspirin is more effective than aspirin alone for preventing thromboembolic disease. Since the approval of clopidogrel by the U.S. Food and Drug Administration (FDA) for routine clinical use, the drug has become one of the most commonly prescribed agents in the United States. However, patient response to clopidogrel-based antiplatelet therapy is variable both between patients and across multiple measurements within a patient, with some patients showing no or minimal platelet response to clopidogrel administration (often termed clopidogrel “nonresponsiveness” or “resistance”). Alternatives to standard clopidogrel treatment include higher dose clopidogrel regimens and the use of other antiplatelet agents, such as prasugrel or ticagrelor. Given the availability of alternative antiplatelet strategies and concern about adverse clinical outcomes in clopidogrel nonresponders, research has focused on methods to identify patients who are unlikely to benefit from clopidogrel-based treatment. The question of identifying the optimal antiplatelet therapy may also carry cost implications because generic clopidogrel products are now available in the United States.

Anticoagulation Therapy

Anticoagulation Therapy
Author: Joe F. Lau,Geoffrey D. Barnes,Michael B. Streiff
Publsiher: Springer
Total Pages: 452
Release: 2018-04-16
ISBN 10: 3319737090
ISBN 13: 9783319737096
Language: EN, FR, DE, ES & NL

Anticoagulation Therapy Book Review:

This book presents the latest evidence and guidelines supporting the use of anticoagulant therapy for various clinical scenarios. The field of anticoagulation therapy is evolving rapidly, particularly since the arrival and widespread adoption of direct oral anticoagulants. Organized in two parts, this book reviews the pharmacologic properties of various anticoagulants and details the clinical applications of anticoagulant therapy. Drugs such as warfarin and unfractionated heparin, as well as parenteral and direct oral anticoagulants are discussed in terms of their pharmacokinetics, drug-disease interactions, dosing strategies, and risk considerations. Clinical applications of anticoagulant therapy in disorders such as acute coronary syndromes, atrial fibrillation, and thrombophilia and in special populations such as pregnant women, the elderly, and in the patient with cancer are highlighted. Clinical vignettes, algorithms, clinical pearls, and self-assessment questions are integrated throughout the book. Featuring contributions from authorities in the field, Anticoagulation Therapy is an essential resource for cardiologists, vascular medicine specialists, hematologists, internists, and all other healthcare professionals who prescribe anticoagulants.